title: Use of Oral Droxidopa to Improve Arterial Pressure and Reduce Vasoactive Drug Requirements During Persistent Vasoplegic Syndrome After Cardiac Transplantation.
authors.affiliation: Departments of Anesthesiology.
authors.forename: M Tracy
authors.initials: MT
authors.lastname: Zundel
authors.affiliation: Departments of Anesthesiology.
authors.forename: Brent T
authors.initials: BT
authors.lastname: Boettcher
authors.affiliation: Pharmacy, Medical College of Wisconsin, Milwaukee, WI.
authors.forename: Joel T
authors.initials: JT
authors.lastname: Feih
authors.affiliation: Cardiology.
authors.forename: Nunzio
authors.initials: N
authors.lastname: Gaglianello
authors.affiliation: Anesthesia Service, Clement J. Zablocki Veterans Affairs Medical Center, Milwaukee, WI. Electronic address: pspagel@mcw.edu.
authors.forename: Paul S
authors.initials: PS
authors.lastname: Pagel
mesh_terms: D000284:Administration, Oral; D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D062186:Arterial Pressure / Q000187:drug effects*; D015103:Droxidopa / Q000008:administration & dosage / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D008875:Middle Aged; D009102:Multiple Organ Failure; D011183:Postoperative Complications / Q000188:drug therapy* / Q000503:physiopathology; D013577:Syndrome; D056987:Vasoplegia / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000978:Antiparkinson Agents; D015103:Droxidopa
keywords: 4-dihydroxyphenylserine (L-DOPS); L-threo-3; cardiac transplantation; droxidopa; norepinephrine; phenylephrine; vasoactive drugs; vasoplegic syndrome; vasopressin